Perioperative Pembrolizumab for Early-Stage Non–Small-Cell Lung CancerHeather A. Wakelee, Jonathan Spicer, Christophe Dooms et al.|New England Journal of Medicine|2023Cited by 1k
Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trialJonathan Spicer, Marina Chiara Garassino, Heather A. Wakelee et al.|The Lancet|2024Cited by 233
Abstract PR005: An atlas of cellular heterogeneity in primary and metastatic renal cell carcinomasAriel Madrigal, Hamed S. Najafabadi, Minjun Kim et al.|Cancer Research|2023Cited by 0
Abstract 2184: Defining cancer initiating cells and their vulnerabilities in renal cell carcinoma.Zohreh Mehrjoo, Y. Riazalhosseini, Hellen Kuasne et al.|Cancer Research|2026Cited by 0